Journal of Translational Medicine (Apr 2022)
Propranolol as therapy for cerebral cavernous malformations: a cautionary note
- Robert Shenkar,
- Thomas Moore,
- Christian Benavides,
- Rhonda Lightle,
- Matthew R. Detter,
- Nicholas Hobson,
- Romuald Girard,
- Dorothy DeBiasse,
- Mary Patrucco,
- Carol Gallione,
- Joseph M. Zabramski,
- Douglas A. Marchuk,
- Issam A. Awad
Affiliations
- Robert Shenkar
- Department of Neurological Surgery, University of Chicago Medicine and Biological Sciences
- Thomas Moore
- Department of Neurological Surgery, University of Chicago Medicine and Biological Sciences
- Christian Benavides
- Department of Molecular Genetics and Microbiology, Duke University
- Rhonda Lightle
- Department of Neurological Surgery, University of Chicago Medicine and Biological Sciences
- Matthew R. Detter
- Department of Molecular Genetics and Microbiology, Duke University
- Nicholas Hobson
- Department of Neurological Surgery, University of Chicago Medicine and Biological Sciences
- Romuald Girard
- Department of Neurological Surgery, University of Chicago Medicine and Biological Sciences
- Dorothy DeBiasse
- Department of Neurological Surgery, University of Chicago Medicine and Biological Sciences
- Mary Patrucco
- Department of Molecular Genetics and Microbiology, Duke University
- Carol Gallione
- Department of Molecular Genetics and Microbiology, Duke University
- Joseph M. Zabramski
- Department of Neurosurgery, Barrow Neurological Institute
- Douglas A. Marchuk
- Department of Molecular Genetics and Microbiology, Duke University
- Issam A. Awad
- Department of Neurological Surgery, University of Chicago Medicine and Biological Sciences
- DOI
- https://doi.org/10.1186/s12967-022-03360-4
- Journal volume & issue
-
Vol. 20,
no. 1
pp. 1 – 3
Abstract
No abstracts available.